25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Intelgenx Technologs
Buy, Hold or Sell?

Let's analyze Intelgenx together

I guess you are interested in Intelgenx Technologs. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Intelgenx Technologs. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Intelgenx Technologs

I send you an email if I find something interesting about Intelgenx Technologs.

1. Quick Overview

1.1. Quick analysis of Intelgenx (30 sec.)










1.2. What can you expect buying and holding a share of Intelgenx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.07
Expected worth in 1 year
$-0.27
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.20
Return On Investment
-118.9%

For what price can you sell your share?

Current Price per Share
$0.17
Expected price per share
$0.17 - $0.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Intelgenx (5 min.)




Live pricePrice per Share (EOD)
$0.17
Intrinsic Value Per Share
$-0.45 - $-0.14
Total Value Per Share
$-0.52 - $-0.21

2.2. Growth of Intelgenx (5 min.)




Is Intelgenx growing?

Current yearPrevious yearGrowGrow %
How rich?-$12.2m-$3.4m-$8.8m-72.1%

How much money is Intelgenx making?

Current yearPrevious yearGrowGrow %
Making money-$9.9m-$11.9m$2m20.6%
Net Profit Margin-955.4%-1,259.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Intelgenx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Intelgenx?

Welcome investor! Intelgenx's management wants to use your money to grow the business. In return you get a share of Intelgenx.

First you should know what it really means to hold a share of Intelgenx. And how you can make/lose money.

Speculation

The Price per Share of Intelgenx is $0.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intelgenx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intelgenx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.07. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intelgenx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-33.4%-0.06-33.4%-0.06-36.0%-0.05-32.1%-0.04-21.0%
Usd Book Value Change Per Share-0.05-29.7%-0.05-29.7%-0.04-24.6%-0.03-15.0%-0.01-5.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-29.7%-0.05-29.7%-0.04-24.6%-0.03-15.0%-0.01-5.8%
Usd Price Per Share0.14-0.14-0.20-0.28-0.45-
Price to Earnings Ratio-2.46--2.46--3.27--5.13--17.70-
Price-to-Total Gains Ratio-2.77--2.77--4.79--6.77--47.82-
Price to Book Ratio-2.00--2.00--10.20-48.78-35.30-
Price-to-Total Gains Ratio-2.77--2.77--4.79--6.77--47.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.17
Number of shares5882
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.03
Usd Total Gains Per Share-0.05-0.03
Gains per Quarter (5882 shares)-297.17-149.76
Gains per Year (5882 shares)-1,188.67-599.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1189-11990-599-609
20-2377-23880-1198-1208
30-3566-35770-1797-1807
40-4755-47660-2396-2406
50-5943-59550-2995-3005
60-7132-71440-3594-3604
70-8321-83330-4193-4203
80-9509-95220-4792-4802
90-10698-107110-5391-5401
100-11887-119000-5990-6000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.017.00.05.6%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%7.011.00.038.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.018.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%7.011.00.038.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Intelgenx Technologs compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.051-0.0510%-0.042-17%-0.025-50%-0.010-80%
Book Value Per Share---0.070-0.0700%-0.020-72%-0.014-80%0.009-845%
Current Ratio--0.4090.4090%1.596-74%1.000-59%1.934-79%
Debt To Asset Ratio--2.4792.4790%1.372+81%1.339+85%0.917+170%
Debt To Equity Ratio----0%-0%8.047-100%4.624-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.057-0.0570%-0.061+8%-0.055-4%-0.036-37%
Free Cash Flow Per Share---0.038-0.0380%-0.056+46%-0.044+14%-0.034-13%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.039+9708%-0.009+2241%0.000+178%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.136--------
Intrinsic Value_10Y_min---0.445--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.046--------
Intrinsic Value_3Y_max---0.076--------
Intrinsic Value_3Y_min---0.137--------
Intrinsic Value_5Y_max---0.109--------
Intrinsic Value_5Y_min---0.228--------
Market Cap29691860.000+18%24452120.00024452120.0000%34931600.000-30%48554924.000-50%79240588.020-69%
Net Profit Margin---9.554-9.5540%-12.597+32%-9.910+4%-5.671-41%
Operating Margin---8.134-8.1340%-9.908+22%-7.959-2%-4.618-43%
Operating Ratio--10.27810.2780%10.908-6%9.454+9%6.070+69%
Pb Ratio-2.424-21%-1.997-1.9970%-10.205+411%48.778-104%35.298-106%
Pe Ratio-2.991-21%-2.463-2.4630%-3.268+33%-5.128+108%-17.703+619%
Price Per Share0.170+18%0.1400.1400%0.200-30%0.278-50%0.454-69%
Price To Free Cash Flow Ratio-4.428-21%-3.647-3.6470%-3.569-2%-6.357+74%-37.823+937%
Price To Total Gains Ratio-3.365-21%-2.771-2.7710%-4.789+73%-6.767+144%-47.819+1626%
Quick Ratio--0.3650.3650%1.985-82%1.241-71%2.381-85%
Return On Assets---1.199-1.1990%-1.302+9%-0.968-19%-0.580-52%
Return On Equity----0%-0%-8.5810%-4.5100%
Total Gains Per Share---0.051-0.0510%-0.042-17%-0.025-50%-0.010-80%
Usd Book Value---12247000.000-12247000.0000%-3423000.000-72%-2491800.000-80%1643900.000-845%
Usd Book Value Change Per Share---0.051-0.0510%-0.042-17%-0.025-50%-0.010-80%
Usd Book Value Per Share---0.070-0.0700%-0.020-72%-0.014-80%0.009-845%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.057-0.0570%-0.061+8%-0.055-4%-0.036-37%
Usd Free Cash Flow---6705000.000-6705000.0000%-9787000.000+46%-7677000.000+14%-5858100.000-13%
Usd Free Cash Flow Per Share---0.038-0.0380%-0.056+46%-0.044+14%-0.034-13%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.039+9708%-0.009+2241%0.000+178%
Usd Market Cap29691860.000+18%24452120.00024452120.0000%34931600.000-30%48554924.000-50%79240588.020-69%
Usd Price Per Share0.170+18%0.1400.1400%0.200-30%0.278-50%0.454-69%
Usd Profit---9927000.000-9927000.0000%-11967000.000+21%-10263800.000+3%-6611300.000-33%
Usd Revenue--1039000.0001039000.0000%950000.000+9%1162000.000-11%2480300.000-58%
Usd Total Gains Per Share---0.051-0.0510%-0.042-17%-0.025-50%-0.010-80%
 EOD+6 -2MRQTTM+0 -0YOY+16 -155Y+11 -2110Y+6 -26

3.3 Fundamental Score

Let's check the fundamental score of Intelgenx Technologs based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.991
Price to Book Ratio (EOD)Between0-1-2.424
Net Profit Margin (MRQ)Greater than0-9.554
Operating Margin (MRQ)Greater than0-8.134
Quick Ratio (MRQ)Greater than10.365
Current Ratio (MRQ)Greater than10.409
Debt to Asset Ratio (MRQ)Less than12.479
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.199
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Intelgenx Technologs based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.566
Ma 20Greater thanMa 500.170
Ma 50Greater thanMa 1000.170
Ma 100Greater thanMa 2000.170
OpenGreater thanClose0.170
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Intelgenx Technologs

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-11-15 02:00:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Intelgenx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Net Profit Margin of -955.4% means that $-9.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intelgenx Technologs:

  • The MRQ is -955.4%. The company is making a huge loss. -2
  • The TTM is -955.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-955.4%TTM-955.4%0.0%
TTM-955.4%YOY-1,259.7%+304.2%
TTM-955.4%5Y-991.0%+35.6%
5Y-991.0%10Y-567.1%-424.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-955.4%-120.2%-835.2%
TTM-955.4%-210.7%-744.7%
YOY-1,259.7%-219.8%-1,039.9%
5Y-991.0%-348.0%-643.0%
10Y-567.1%-473.2%-93.9%
4.3.1.2. Return on Assets

Shows how efficient Intelgenx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • -119.9% Return on Assets means that Intelgenx generated $-1.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intelgenx Technologs:

  • The MRQ is -119.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -119.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-119.9%TTM-119.9%0.0%
TTM-119.9%YOY-130.2%+10.4%
TTM-119.9%5Y-96.8%-23.1%
5Y-96.8%10Y-58.0%-38.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-119.9%-11.0%-108.9%
TTM-119.9%-11.8%-108.1%
YOY-130.2%-11.3%-118.9%
5Y-96.8%-12.6%-84.2%
10Y-58.0%-14.3%-43.7%
4.3.1.3. Return on Equity

Shows how efficient Intelgenx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • 0.0% Return on Equity means Intelgenx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intelgenx Technologs:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-858.1%+858.1%
5Y-858.1%10Y-451.0%-407.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.8%+15.8%
YOY--13.9%+13.9%
5Y-858.1%-18.5%-839.6%
10Y-451.0%-19.2%-431.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Intelgenx Technologs.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Intelgenx is operating .

  • Measures how much profit Intelgenx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • An Operating Margin of -813.4% means the company generated $-8.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intelgenx Technologs:

  • The MRQ is -813.4%. The company is operating very inefficient. -2
  • The TTM is -813.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-813.4%TTM-813.4%0.0%
TTM-813.4%YOY-990.8%+177.5%
TTM-813.4%5Y-795.9%-17.4%
5Y-795.9%10Y-461.8%-334.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-813.4%-267.8%-545.6%
TTM-813.4%-313.4%-500.0%
YOY-990.8%-224.0%-766.8%
5Y-795.9%-385.5%-410.4%
10Y-461.8%-498.7%+36.9%
4.3.2.2. Operating Ratio

Measures how efficient Intelgenx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.28 means that the operating costs are $10.28 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Intelgenx Technologs:

  • The MRQ is 10.278. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.278. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.278TTM10.2780.000
TTM10.278YOY10.908-0.630
TTM10.2785Y9.454+0.824
5Y9.45410Y6.070+3.384
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2782.631+7.647
TTM10.2783.412+6.866
YOY10.9083.299+7.609
5Y9.4544.788+4.666
10Y6.0706.538-0.468
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Intelgenx Technologs.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Intelgenx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.41 means the company has $0.41 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.409. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.409. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.409TTM0.4090.000
TTM0.409YOY1.596-1.187
TTM0.4095Y1.000-0.592
5Y1.00010Y1.934-0.934
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4093.690-3.281
TTM0.4093.875-3.466
YOY1.5964.684-3.088
5Y1.0005.946-4.946
10Y1.9346.274-4.340
4.4.3.2. Quick Ratio

Measures if Intelgenx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Quick Ratio of 0.36 means the company can pay off $0.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.365. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.365. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.3650.000
TTM0.365YOY1.985-1.620
TTM0.3655Y1.241-0.876
5Y1.24110Y2.381-1.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3653.122-2.757
TTM0.3653.451-3.086
YOY1.9854.498-2.513
5Y1.2415.922-4.681
10Y2.3816.414-4.033
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Intelgenx Technologs.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Intelgenx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Intelgenx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.48 means that Intelgenx assets are financed with 247.9% credit (debt) and the remaining percentage (100% - 247.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Intelgenx Technologs:

  • The MRQ is 2.479. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.479. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.479TTM2.4790.000
TTM2.479YOY1.372+1.106
TTM2.4795Y1.339+1.140
5Y1.33910Y0.917+0.422
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4790.353+2.126
TTM2.4790.350+2.129
YOY1.3720.311+1.061
5Y1.3390.367+0.972
10Y0.9170.382+0.535
4.5.4.2. Debt to Equity Ratio

Measures if Intelgenx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y8.047-8.047
5Y8.04710Y4.624+3.424
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.435-0.435
YOY-0.378-0.378
5Y8.0470.451+7.596
10Y4.6240.493+4.131
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Intelgenx generates.

  • Above 15 is considered overpriced but always compare Intelgenx to the Biotechnology industry mean.
  • A PE ratio of -2.46 means the investor is paying $-2.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intelgenx Technologs:

  • The EOD is -2.991. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.463. Based on the earnings, the company is expensive. -2
  • The TTM is -2.463. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.991MRQ-2.463-0.528
MRQ-2.463TTM-2.4630.000
TTM-2.463YOY-3.268+0.804
TTM-2.4635Y-5.128+2.665
5Y-5.12810Y-17.703+12.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.991-2.126-0.865
MRQ-2.463-2.454-0.009
TTM-2.463-3.147+0.684
YOY-3.268-3.335+0.067
5Y-5.128-6.070+0.942
10Y-17.703-6.597-11.106
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intelgenx Technologs:

  • The EOD is -4.428. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.647. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.647. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.428MRQ-3.647-0.781
MRQ-3.647TTM-3.6470.000
TTM-3.647YOY-3.569-0.078
TTM-3.6475Y-6.357+2.711
5Y-6.35710Y-37.823+31.465
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.428-2.981-1.447
MRQ-3.647-3.363-0.284
TTM-3.647-3.667+0.020
YOY-3.569-4.535+0.966
5Y-6.357-8.343+1.986
10Y-37.823-9.276-28.547
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Intelgenx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -2.00 means the investor is paying $-2.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Intelgenx Technologs:

  • The EOD is -2.424. Based on the equity, the company is expensive. -2
  • The MRQ is -1.997. Based on the equity, the company is expensive. -2
  • The TTM is -1.997. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.424MRQ-1.997-0.428
MRQ-1.997TTM-1.9970.000
TTM-1.997YOY-10.205+8.208
TTM-1.9975Y48.778-50.775
5Y48.77810Y35.298+13.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.4241.863-4.287
MRQ-1.9972.028-4.025
TTM-1.9972.339-4.336
YOY-10.2052.391-12.596
5Y48.7783.666+45.112
10Y35.2984.360+30.938
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets8,282
Total Liabilities20,529
Total Stockholder Equity-12,247
 As reported
Total Liabilities 20,529
Total Stockholder Equity+ -12,247
Total Assets = 8,282

Assets

Total Assets8,282
Total Current Assets3,441
Long-term Assets4,841
Total Current Assets
Cash And Cash Equivalents 2,282
Net Receivables 790
Inventory 71
Other Current Assets 298
Total Current Assets  (as reported)3,441
Total Current Assets  (calculated)3,441
+/-0
Long-term Assets
Property Plant Equipment 4,591
Long-term Assets Other 250
Long-term Assets  (as reported)4,841
Long-term Assets  (calculated)4,841
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,423
Long-term Liabilities12,106
Total Stockholder Equity-12,247
Total Current Liabilities
Short-term Debt 3,733
Short Long Term Debt 3,057
Accounts payable 2,661
Other Current Liabilities 2,498
Total Current Liabilities  (as reported)8,423
Total Current Liabilities  (calculated)11,949
+/- 3,526
Long-term Liabilities
Long term Debt 11,839
Capital Lease Obligations 605
Long-term Liabilities  (as reported)12,106
Long-term Liabilities  (calculated)12,444
+/- 338
Total Stockholder Equity
Common Stock1
Retained Earnings -78,457
Accumulated Other Comprehensive Income -2,453
Total Stockholder Equity (as reported)-12,247
Total Stockholder Equity (calculated)-80,909
+/- 68,662
Other
Capital Stock1
Cash and Short Term Investments 2,282
Common Stock Shares Outstanding 174,655
Current Deferred Revenue1,118
Liabilities and Stockholders Equity 8,282
Net Debt 13,219
Net Invested Capital 2,649
Net Working Capital -4,982
Property Plant and Equipment Gross 10,570
Short Long Term Debt Total 15,501



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
0
0
651
1,271
1,622
2,862
1,825
4,570
4,159
6,217
6,284
8,916
12,790
13,147
20,018
11,020
11,118
17,905
9,190
8,282
8,2829,19017,90511,11811,02020,01813,14712,7908,9166,2846,2174,1594,5701,8252,8621,6221,27165100
   > Total Current Assets 
0
0
489
1,036
1,464
2,703
1,666
4,296
3,656
5,550
5,255
4,172
6,352
6,044
13,063
3,220
4,305
11,437
3,788
3,441
3,4413,78811,4374,3053,22013,0636,0446,3524,1725,2555,5503,6564,2961,6662,7031,4641,03648900
       Cash And Cash Equivalents 
0
0
228
331
556
1,525
1,144
3,505
2,059
5,005
4,399
2,865
612
1,591
6,815
1,332
1,205
3,945
1,210
2,282
2,2821,2103,9451,2051,3326,8151,5916122,8654,3995,0052,0593,5051,1441,52555633122800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
3,884
3,313
4,180
580
1,038
6,004
1,317
0
01,3176,0041,0385804,1803,3133,884000000000000
       Net Receivables 
0
0
188
682
586
1,130
475
723
1,495
412
760
1,237
1,290
937
1,231
756
1,249
1,116
868
790
7908681,1161,2497561,2319371,2901,2377604121,4957234751,13058668218800
       Other Current Assets 
0
0
73
0
322
48
47
68
102
133
96
70
566
203
462
170
569
310
331
298
298331310569170462203566709613310268474832207300
   > Long-term Assets 
0
0
162
235
157
158
159
274
503
667
1,029
4,744
6,438
7,103
6,955
7,800
6,813
6,468
5,402
4,841
4,8415,4026,4686,8137,8006,9557,1036,4384,7441,02966750327415915815723516200
       Property Plant Equipment 
0
0
162
235
157
158
159
149
387
588
983
4,238
5,730
6,346
6,248
7,048
6,561
6,216
5,157
4,591
4,5915,1576,2166,5617,0486,2486,3465,7304,23898358838714915915815723516200
       Intangible Assets 
0
0
0
0
0
0
0
125
116
79
46
0
0
0
0
0
0
0
0
0
00000000046791161250000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
506
708
757
707
752
252
252
245
0
024525225275270775770850600000000000
> Total Liabilities 
4
22
323
1,059
1,450
705
349
666
1,981
1,209
1,711
3,352
7,845
9,318
10,031
10,727
12,071
14,034
12,613
20,529
20,52912,61314,03412,07110,72710,0319,3187,8453,3521,7111,2091,9816663497051,4501,059323224
   > Total Current Liabilities 
4
22
154
261
1,368
705
349
666
1,366
901
1,711
1,779
5,235
2,077
2,722
8,447
4,368
7,020
2,374
8,423
8,4232,3747,0204,3688,4472,7222,0775,2351,7791,7119011,3666663497051,368261154224
       Short-term Debt 
0
0
24
418
715
0
0
0
0
0
0
184
704
772
692
6,506
2,213
4,532
544
3,733
3,7335444,5322,2136,5066927727041840000007154182400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
184
704
772
692
6,369
2,047
4,247
0
3,057
3,05704,2472,0476,36969277270418400000000000
       Accounts payable 
2
0
130
261
0
0
0
0
1,058
593
466
1,595
897
1,305
2,030
1,941
1,989
2,299
1,523
2,661
2,6611,5232,2991,9891,9412,0301,3058971,5954665931,058000026113002
       Other Current Liabilities 
4
22
0
-418
653
705
349
666
1,058
593
466
0
3,634
1,305
2,030
1,941
332
189
307
2,498
2,4983071893321,9412,0301,3053,63404665931,058666349705653-4180224
   > Long-term Liabilities 
0
0
169
798
82
0
0
0
615
308
0
1,573
2,610
7,241
7,309
2,280
7,703
7,014
10,239
12,106
12,10610,2397,0147,7032,2807,3097,2412,6101,57303086150008279816900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
2,610
7,241
7,309
1,725
7,137
0
0
0
0007,1371,7257,3097,2412,610000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
615
308
0
27
45
50
49
0
0
79
0
0
00790049504527030861500000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
308
0
27
45
50
0
0
0
0
0
0
0000005045270308000000000
> Total Stockholder Equity
-4
-22
328
212
172
2,157
1,476
3,904
2,178
5,008
4,573
5,564
4,945
3,829
9,987
293
-953
3,871
-3,423
-12,247
-12,247-3,4233,871-9532939,9873,8294,9455,5644,5735,0082,1783,9041,4762,157172212328-22-4
   Common Stock
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
11111111111000000000
   Retained Earnings -78,457-68,530-57,863-48,551-41,507-30,896-20,788-17,737-16,557-17,848-16,102-14,463-12,213-9,761-6,665-4,725-1,919-818-23-4
   Capital Surplus 
0
0
0
0
0
0
0
0
0
20,934
22,654
0
23,700
25,253
42,048
42,635
48,453
0
0
0
00048,45342,63542,04825,25323,700022,65420,934000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
1
1,166
153
5,081
8,810
11,087
15,918
16,342
20,934
22,654
22,846
23,700
25,253
42,048
42,635
48,453
63,104
67,340
137,324
137,32467,34063,10448,45342,63542,04825,25323,70022,84622,65420,93416,34215,91811,0878,8105,0811531,16610



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,039
Cost of Revenue-2,499
Gross Profit-1,460-1,460
 
Operating Income (+$)
Gross Profit-1,460
Operating Expense-8,180
Operating Income-9,640-9,640
 
Operating Expense (+$)
Research Development3,423
Selling General Administrative4,757
Selling And Marketing Expenses0
Operating Expense8,1808,180
 
Net Interest Income (+$)
Interest Income41
Interest Expense-1,625
Other Finance Cost-0
Net Interest Income-1,584
 
Pretax Income (+$)
Operating Income-9,640
Net Interest Income-1,584
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,076-9,055
EBIT - interestExpense = -10,076
-10,076
-8,302
Interest Expense1,625
Earnings Before Interest and Taxes (EBIT)-8,451-8,451
Earnings Before Interest and Taxes (EBITDA)-7,685
 
After tax Income (+$)
Income Before Tax-10,076
Tax Provision-0
Net Income From Continuing Ops-9,927-10,076
Net Income-9,927
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,679
Total Other Income/Expenses Net-5851,584
 

Technical Analysis of Intelgenx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intelgenx. The general trend of Intelgenx is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intelgenx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intelgenx Technologs.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.17 < 0.17 < 0.17.

The bearish price targets are: 0.17 > 0.17 > 0.17.

Tweet this
Intelgenx Technologs Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intelgenx Technologs. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intelgenx Technologs Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intelgenx Technologs. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Intelgenx price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Intelgenx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Intelgenx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Intelgenx Technologs Daily Moving Average Convergence/Divergence (MACD) ChartIntelgenx Technologs Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intelgenx Technologs. The current adx is 23.08.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Intelgenx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Intelgenx Technologs Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intelgenx Technologs. The current sar is 0.1718814.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Intelgenx Technologs Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intelgenx Technologs. The current rsi is 50.57. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Intelgenx Technologs Daily Relative Strength Index (RSI) ChartIntelgenx Technologs Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intelgenx Technologs. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Intelgenx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Intelgenx Technologs Daily Stochastic Oscillator ChartIntelgenx Technologs Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intelgenx Technologs. The current cci is 66.67.

Intelgenx Technologs Daily Commodity Channel Index (CCI) ChartIntelgenx Technologs Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intelgenx Technologs. The current cmo is 0.

Intelgenx Technologs Daily Chande Momentum Oscillator (CMO) ChartIntelgenx Technologs Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intelgenx Technologs. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Intelgenx Technologs Daily Williams %R ChartIntelgenx Technologs Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Intelgenx Technologs.

Intelgenx Technologs Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intelgenx Technologs. The current atr is 0.00000.

Intelgenx Technologs Daily Average True Range (ATR) ChartIntelgenx Technologs Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intelgenx Technologs. The current obv is -1,170,299.

Intelgenx Technologs Daily On-Balance Volume (OBV) ChartIntelgenx Technologs Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intelgenx Technologs. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Intelgenx Technologs Daily Money Flow Index (MFI) ChartIntelgenx Technologs Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intelgenx Technologs.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Intelgenx Technologs Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intelgenx Technologs based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.566
Ma 20Greater thanMa 500.170
Ma 50Greater thanMa 1000.170
Ma 100Greater thanMa 2000.170
OpenGreater thanClose0.170
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Intelgenx with someone you think should read this too:
  • Are you bullish or bearish on Intelgenx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intelgenx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intelgenx Technologs

I send you an email if I find something interesting about Intelgenx Technologs.


Comments

How you think about this?

Leave a comment

Stay informed about Intelgenx Technologs.

Receive notifications about Intelgenx Technologs in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.